Original Research

Accepted on 04 Nov 2024

A New Perspective on Macrophage-targeted Drug Research: The Potential of KDELR2 in Bladder Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Zhiyi Zhao
Hongling Jia
Zhou Sun
Yumeng Li
Lingyun Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485109

102 views

Original Research

Accepted on 04 Nov 2024

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Xin Wang
Lang Jiang
Juan Zhao
Mi Wu
Jin Xiong
Xiongwen Wu
Xiufang Weng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1456209

Review

Accepted on 04 Nov 2024

Tumor-Infiltrating Lymphocytes in Melanoma: From Prognostic Assessment to Therapeutic Applications

in Cancer Immunity and Immunotherapy

Meshack Bida
Thabiso Victor Miya
Rodney Hull
Zodwa Dlamini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497522

Original Research

Accepted on 04 Nov 2024

Identification of anoikis-related molecular patterns and the novel risk model to predict prognosis, tumor microenvironment infiltration and immunotherapy response in bladder cancer

in Cancer Immunity and Immunotherapy

Luochen Zhu
Feng Xiao
Yi Hou
Shenjun Huang
Yanyan Xu
Xiaohong Guo
Xinwei Dong
Chunlu Xu
Xiaolei Zhang
Haijuan Gu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1491808

Review

Accepted on 04 Nov 2024

c-MET and the Immunological Landscape of Cancer: Novel Therapeutic Strategies for Enhanced Anti-Tumor Immunity

in Cancer Immunity and Immunotherapy

Parham Jabbarzadeh Kaboli
Ghazaal Roozitalab
Reyhaneh Farghadani
Zoya Eskandarian
Abdessamad Zerrouqi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498391

107 views

Original Research

Published on 04 Nov 2024

Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma

in Cancer Immunity and Immunotherapy

Shuping Wu
Yu Liu
Yu Zeng
Xianhui Ruan
Mei Tao
Wenrong Lin
Chang Liu
Hongbin Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463258

737 views

Original Research

Published on 04 Nov 2024

Identification of novel markers for neuroblastoma immunoclustering using machine learning

in Cancer Immunity and Immunotherapy

Longguo Zhang
Huixin Li
Fangyan Sun
Qiuping Wu
Leigang Jin
Aimin Xu
Jiarui Chen
Ranyao Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446273

607 views

Original Research

Published on 04 Nov 2024

Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Peikai Ding
Shengbin Pei
Zheng Qu
Yazhe Yang
Qiang Liu
Xiangyi Kong
Zhongzhao Wang
Jing Wang
Yi Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1489444

703 views

Original Research

Published on 04 Nov 2024

Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model

in Cancer Immunity and Immunotherapy

Alexis R. Steinmetz
Morgan Pierce
Alberto Martini
Come Tholomier
Ganiraju Manyam
Yan Chen
Akshay Sood
Jonathan J. Duplisea
Burles A. Johnson
Bogdan A. Czerniak

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387229

1,177 views

Review

Published on 04 Nov 2024

Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis

in Cancer Immunity and Immunotherapy

Tiantian Yang
Wanru Luo
Jie Yu
Huiping Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481296

446 views

Original Research

Published on 04 Nov 2024

Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study

in Cancer Immunity and Immunotherapy

Xue-Mei You
Fei-Chen Lu
Fan-Rong Li
Feng-Juan Zhao
Rong-Rui Huo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1463655

443 views

Mini Review

Published on 04 Nov 2024

A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis

in Cancer Immunity and Immunotherapy

Lin Zhou
Shuhui Yang
Youtao Li
Cheng Xue
Renping Wan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448728

614 views

Review

Published on 01 Nov 2024

Clinical immunotherapy in glioma: current concepts, challenges, and future perspectives

in Cancer Immunity and Immunotherapy

Jun Liu
Jingjian Peng
Jian Jiang
Yanhui Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476436

787 views

Original Research

Published on 01 Nov 2024

The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab

in Cancer Immunity and Immunotherapy

Weijie Wu
Zhenyun Yang
Hao Zou
Teng Long
Zhongguo Zhou
Yaojun Zhang
Minshan Chen
Dandan Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474456

608 views

Original Research

Published on 01 Nov 2024

The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy

in Cancer Immunity and Immunotherapy

Xiaoli Xia
Yixin Wang
Minghui Wang
Jian Lin
Ruiheng Wang
Shufeng Xie
Yaoyifu Yu
Jinlan Long
Zixuan Huang
Huajian Xian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451796

745 views

Review

Published on 01 Nov 2024

Macrophages in tumor cell migration and metastasis

in Cancer Immunity and Immunotherapy

Madeline Friedman-DeLuca
George S. Karagiannis
John S. Condeelis
Maja H. Oktay
David Entenberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494462

668 views

Navigation group

Articles

A New Perspective on Macrophage-targeted Drug Research: The Potential of KDELR2 in Bladder Cancer Immunotherapy

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma

Tumor-Infiltrating Lymphocytes in Melanoma: From Prognostic Assessment to Therapeutic Applications

Identification of anoikis-related molecular patterns and the novel risk model to predict prognosis, tumor microenvironment infiltration and immunotherapy response in bladder cancer

c-MET and the Immunological Landscape of Cancer: Novel Therapeutic Strategies for Enhanced Anti-Tumor Immunity

Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma

Identification of novel markers for neuroblastoma immunoclustering using machine learning

Single-cell sequencing unveils mitophagy-related prognostic model for triple-negative breast cancer

Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model

Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis

Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study

A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis

Clinical immunotherapy in glioma: current concepts, challenges, and future perspectives

The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab

The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy

Macrophages in tumor cell migration and metastasis